Member Info for The-Hat

I'm in both, holding ncyt for news.

Depends on which one gets the news first, GDR probably has further to go but if RNS drops in NCYT tomorrow could move alot more money here.

Not true unless you consider mm's buyers. They can take your shares and hold for a buyer.

CASH +R&D=Results

I had just set a sell at 2.90 to top slice when the RNS dropped awful timing, sell didn't go through.
Now I feel GDR are in a much better place fully funded to maximise the cash cow that COVID 19 will be. That cash will drive all other products and R&D. Potential here is off the scale. Cash=R&D= results.

Admission occurring no later than 8.00 a.m. (London time) on 28 May 2020 (or such later time and/or date, not being later than 8.00 a.m. (London time) on 11 June 2020, as the Bookrunners may otherwise agree with the Company) (the "Closing Date")

28th of May from what I could make out, admit I dont understand half what it said.
"It is expected that Admission of the New Ordinary Shares will occur at or before 8.00 a.m. (London time) on 28 May 2020 (or such later time and/or date as the Bookrunners may agree with the Company) and that dealings in the New Ordinary Shares will commence at that time."

The Company is seeking to enter the novel COVID-19 diagnostics market. The Directors believe it is impossible to predict the full nature, extent and duration of the COVID-19 pandemic and therefore the total demand for COVID-19 diagnostic tests and the longevity of this demand are uncertain. Furthermore, the introduction of breakthrough therapeutic drugs or vaccines could reduce the requirement for widescale diagnostic testing of COVID-19 and the importance of contact tracing.



The ability of the Company to commercialise its COVID-19 tests is dependent on the ability to obtain regulatory approvals in relevant markets. genedrive intends to obtain a CE mark for its COVID-19 tests but the tests are currently unapproved. Under section 564 of the Federal Food, Drug, and Cosmetic Act, the FDA Commissioner may allow unapproved medical products or unapproved uses of approved medical products to be used in an emergency to diagnose, treat, or prevent serious or life-threatening diseases or conditions caused by a terrorist attack with a biological, chemical, or radiological/nuclear material, or a naturally occurring emerging disease when there are no adequate, approved, and available alternatives (Emergency Use Approval). On 4 February 2020, the US Department of Health and Human Services Secretary declared that circumstances exist justifying the authorisation of emergency use of in vitro diagnostics for detection and/or diagnosis of the virus that causes COVID-19. On 29 February 2020, the FDA issued an immediately in effect guidance with policy specific to development of in vitro diagnostic tests during this public health emergency, which was subsequently updated on 16 March 2020. There is no certainty that the FDA will continue to allow Emergency Use Authorisation either due to the development of adequate, approved and available alternatives or due to the COVID-19 pandemic no longer being considered sufficiently serious to justify emergency use of in vitro diagnostics. If the FDA withdraws the Emergency Use Approval, the ability of the Company to commercialise its COVID-19 diagnostic tests would be adversely affected in the US and other markets.

Sensible statement and staying grounded.

@Hyper that was my attempt at sarcasm...making the point that they have lots of products HCV test being to the fore at the moment.

I thought that yesterdays RNS was about a HCV test that will sell millions???

Pharma margins are nearly always 80%-90% and a lot more in some cases. Pretty normal for the sector.

No issue with the placing, can only be good in the long term. Dropping it after opening when a surge was almost guaranteed after yesterdays RNS.

60% margin would be the minimum I woiuld think.

Could they have not released at 7am. They knew the Share price was going to taje-off after yesterdays RNS and buyers were going to get spiked. Maybe tey will drop another Glorious RNS this evening or tomorrow moring to make up for it? ; )

I meant 25% still stand by 275 : )

275 finish Dilution was around 5% was heading north of 300 when rns dropped.

@therealmaka. I was trying to top slice today at 200 but sale wouldnt go through. Glad now though.
You top slice to take profit, no shame in that.

It's not a drug it's a test?

I am glad now. LOL.

I know that's why I am leaving 2/3 of my shares to ride. There will never be a profit if you dont sell. Be more likely to realise big profits on free rides with out risking capital, no brainer for me anyway.